Citations (10)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Peter MA Calverley, Alberto Papi, Clive Page, Paola Rogliani, Roberto W Dal Negro, Mario Cazzola, Arrigo F Cicero & Jadwiga A Wedzicha. (2022) The Effect of Maintenance Treatment with Erdosteine on Exacerbation Treatment and Health Status in Patients with COPD: A Post-Hoc Analysis of the RESTORE Dataset. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 1909-1920.
Read now
Read now
Fujun Zhou, Cheng Cao, Huiping Chai, Jingfang Hong & Min Zhu. (2021) Circ-HACE1 Aggravates Cigarette Smoke Extract-Induced Injury in Human Bronchial Epithelial Cells via Regulating Toll-Like Receptor 4 by Sponging miR-485-3p. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 1535-1547.
Read now
Read now
Claus F Vogelmeier, Ian P Naya, François Maltais, Leif Bjermer, Edward M Kerwin, Lee Tombs, Paul W Jones, Chris Compton, David A Lipson & Isabelle H Boucot. (2021) Treatment of COPD with Long-Acting Bronchodilators: Association Between Early and Longer-Term Clinically Important Improvement. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 1215-1226.
Read now
Read now
Articles from other publishers (7)
Masaru Suzuki, Isao Matsumoto, Masato Ishida, Yoshiharu Horie, Hideyuki Ban, Wataru Takeuchi, Shunki Nakagawa, Tohru Nakagawa, Tetsuhisa Kitamura & Shigeo Muro. (2023) Investigation of time profile of FEV1 across the onset of potential COPD: a retrospective cohort study using medical checkup data in Japan. Scientific Reports 13:1.
Crossref
Crossref
Nadine Wodwaski & Elaine Webber. (2023) Assessment and Management of COPD. Home Healthcare Now 41:1, pages 6-13.
Crossref
Crossref
Kevin Baßler, Wataru Fujii, Theodore S. Kapellos, Erika Dudkin, Nico Reusch, Ari Horne, Benedikt Reiz, Malte D. Luecken, Collins Osei-Sarpong, Stefanie Warnat-Herresthal, Lorenzo Bonaguro, Jonas Schulte-Schrepping, Allon Wagner, Patrick Günther, Carmen Pizarro, Tina Schreiber, Rainer Knoll, Lisa Holsten, Charlotte Kröger, Elena De Domenico, Matthias Becker, Kristian Händler, Christian T. Wohnhaas, Florian Baumgartner, Meike Köhler, Heidi Theis, Michael Kraut, Marc H. WadsworthIIII, Travis K. Hughes, Humberto J. Ferreira, Emily Hinkley, Ines H. Kaltheuner, Matthias Geyer, Christoph Thiele, Alex K. Shalek, Andreas Feißt, Daniel Thomas, Henning Dickten, Marc Beyer, Patrick Baum, Nir Yosef, Anna C. Aschenbrenner, Thomas Ulas, Jan Hasenauer, Fabian J. Theis, Dirk Skowasch & Joachim L. Schultze. (2022) Alveolar macrophages in early stage COPD show functional deviations with properties of impaired immune activation. Frontiers in Immunology 13.
Crossref
Crossref
Kristián Brat, Jaromír Zatloukal, Kateřina Neumannová, Eva Voláková, Ondřej Kudela, Michal Kopecký, Marek Plutinský & Vladimír Koblížek. (2021) Chronic obstructive pulmonary disease: diagnosis and treatment of stable phase of disease; personalized treatment approach using phenotype features of the disease. Vnitřní lékařství 67:4, pages 230-239.
Crossref
Crossref
Jaromir Zatloukal, Kristian Brat, Katerina Neumannova, Eva Volakova, Karel Hejduk, Eva Kocova, Ondrej Kudela, Michal Kopecky, Marek Plutinsky & Vladimir Koblizek. (2020) Chronic obstructive pulmonary disease - diagnosis and management of stable disease; a personalized approach to care, using the treatable traits concept based on clinical phenotypes. Position paper of the Czech Pneumological and Phthisiological Society. Biomedical Papers 164:4, pages 325-356.
Crossref
Crossref
Roland Buhl, Alberto de la Hoz, Wenqiong Xue, Dave Singh & Gary T. Ferguson. (2020) Efficacy of Tiotropium/Olodaterol Compared with Tiotropium as a First-Line Maintenance Treatment in Patients with COPD Who Are Naïve to LAMA, LABA and ICS: Pooled Analysis of Four Clinical Trials. Advances in Therapy 37:10, pages 4175-4189.
Crossref
Crossref
Yujun Wang, Xiaoyu Lyu, Xiaoling Wu, Li Yu & Ke Hu. (2020) Long non‐coding RNA PVT1, a novel biomarker for chronic obstructive pulmonary disease progression surveillance and acute exacerbation prediction potentially through interaction with microRNA‐146a. Journal of Clinical Laboratory Analysis 34:8.
Crossref
Crossref